Fiche centre
Neurologisch-Verhaltensmedizinische Schmerzklinik Kiel
Kiel — Germany
Essais liés3clinical trials
VilleKiellocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT00134810
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rimegepant 75mg daily dosing | Migraine | Phase 4 | NCT05217927 | Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens | COMPLETED |
| Corabotase | Migraine | Phase 2 | NCT06625060 | MERANTI — A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults | ACTIVE_NOT_RECRUITING |
| Botulinum toxin type A | Myopathies | Phase 2 | NCT00134810 | Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome | COMPLETED |